Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Natasha K Martin

Showing results (1-10 of 156) with videos related to

Pageof 16
Sort By:
The International Journal on Drug Policy|May 13, 2022
Fatal overdose: Predicting to preventAnnick Borquez, Natasha K Martin
The International Journal on Drug Policy|April 22, 2020
The use of mathematical modeling to inform drug policy makingNatasha K Martin, Peter Vickerman
BMC Cancer|June 14, 2011
Bicarbonate and dichloroacetate: evaluating pH altering therapies in a mouse model for metastatic breast cancerIan F Robey, Natasha K Martin
Journal of Theoretical Biology|January 18, 2011
Mathematical modelling of hepatitis C treatment for injecting drug usersNatasha K Martin, Peter Vickerman, Matthew Hickman
Addiction (Abingdon, England)|August 13, 2016
Hepatitis C virus prevention and treatment prioritization-ethical, economic and evidential dimensions of early rather than delayed treatment for people who inject drugsMatthew Hickman, Natasha K Martin, Richard Huxtable
Drug and Alcohol Dependence|December 6, 2011
Understanding the trends in HIV and hepatitis C prevalence amongst injecting drug users in different settings--implications for intervention impactPeter Vickerman, Natasha K Martin, Matthew Hickman
Journal of Hepatology|March 22, 2017
How to eliminate HCV infection by antiviral treatmentNatasha K Martin, Peter Vickerman, Matthew Hickman
Hepatology (Baltimore, Md.)|April 27, 2016
ReplyNatasha K Martin, Peter Vickerman, Matthew Hickman
Statistics in Medicine|May 8, 2021
Discussion of article by Ellenberg and MorrisVictor De Gruttola, Ravi Goyal, Natasha K Martin
Hepatology (Baltimore, Md.)|May 7, 2014
HCV treatment as prevention in prison: key issuesNatasha K Martin, Peter Vickerman, David Goldberg, et al.
Pageof 16

Showing results (1-10 of 156) with videos related to

Sort By:
Pageof 16
The International Journal on Drug Policy|May 13, 2022
Fatal overdose: Predicting to preventAnnick Borquez, Natasha K Martin
The International Journal on Drug Policy|April 22, 2020
The use of mathematical modeling to inform drug policy makingNatasha K Martin, Peter Vickerman
BMC Cancer|June 14, 2011
Bicarbonate and dichloroacetate: evaluating pH altering therapies in a mouse model for metastatic breast cancerIan F Robey, Natasha K Martin
Journal of Theoretical Biology|January 18, 2011
Mathematical modelling of hepatitis C treatment for injecting drug usersNatasha K Martin, Peter Vickerman, Matthew Hickman
Addiction (Abingdon, England)|August 13, 2016
Hepatitis C virus prevention and treatment prioritization-ethical, economic and evidential dimensions of early rather than delayed treatment for people who inject drugsMatthew Hickman, Natasha K Martin, Richard Huxtable
Drug and Alcohol Dependence|December 6, 2011
Understanding the trends in HIV and hepatitis C prevalence amongst injecting drug users in different settings--implications for intervention impactPeter Vickerman, Natasha K Martin, Matthew Hickman
Journal of Hepatology|March 22, 2017
How to eliminate HCV infection by antiviral treatmentNatasha K Martin, Peter Vickerman, Matthew Hickman
Hepatology (Baltimore, Md.)|April 27, 2016
ReplyNatasha K Martin, Peter Vickerman, Matthew Hickman
Statistics in Medicine|May 8, 2021
Discussion of article by Ellenberg and MorrisVictor De Gruttola, Ravi Goyal, Natasha K Martin
Hepatology (Baltimore, Md.)|May 7, 2014
HCV treatment as prevention in prison: key issuesNatasha K Martin, Peter Vickerman, David Goldberg, et al.
Pageof 16